Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration Conference – EIN News

Trusted News Since 1995

A service for global professionals
·
Monday, February 11, 2019

·
476,114,629
Articles


·
3+ Million Readers

News Monitoring and Press Release Distribution Tools

Press Releases

Events & Conferences






Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *